These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8113524)

  • 1. Treating periodontal diseases by blocking tissue-destructive enzymes.
    Golub LM; Wolff M; Roberts S; Lee HM; Leung M; Payonk GS
    J Am Dent Assoc; 1994 Feb; 125(2):163-9; discussion 169-71. PubMed ID: 8113524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host modulation with tetracyclines and their chemically modified analogues.
    Golub LM; Suomalainen K; Sorsa T
    Curr Opin Dent; 1992 Mar; 2():80-90. PubMed ID: 1325849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article.
    Ingman T; Sorsa T; Suomalainen K; Halinen S; Lindy O; Lauhio A; Saari H; Konttinen YT; Golub LM
    J Periodontol; 1993 Feb; 64(2):82-8. PubMed ID: 8433257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases and their inhibition in periodontal treatment.
    Ryan ME; Ramamurthy S; Golub LM
    Curr Opin Periodontol; 1996; 3():85-96. PubMed ID: 8624573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetracyclines inhibit tissue collagenases. Effects of ingested low-dose and local delivery systems.
    Golub LM; Goodson JM; Lee HM; Vidal AM; McNamara TF; Ramamurthy NS
    J Periodontol; 1985 Nov; 56(11 Suppl):93-7. PubMed ID: 3001266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms.
    Golub LM; Lee HM; Ryan ME; Giannobile WV; Payne J; Sorsa T
    Adv Dent Res; 1998 Nov; 12(2):12-26. PubMed ID: 9972117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases.
    Sorsa T; Ding Y; Salo T; Lauhio A; Teronen O; Ingman T; Ohtani H; Andoh N; Takeha S; Konttinen YT
    Ann N Y Acad Sci; 1994 Sep; 732():112-31. PubMed ID: 7978785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetracycline inhibition identifies the cellular sources of collagenase in gingival crevicular fluid in different forms of periodontal diseases.
    Suomalainen K; Halinen S; Ingman T; Lindy O; Saari H; Konttinen YT; Golub LM; Sorsa T
    Drugs Exp Clin Res; 1992; 18(3):99-104. PubMed ID: 1425210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs.
    Rifkin BR; Vernillo AT; Golub LM
    J Periodontol; 1993 Aug; 64(8 Suppl):819-27. PubMed ID: 8410621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease.
    Golub LM; Ramamurthy N; McNamara TF; Gomes B; Wolff M; Casino A; Kapoor A; Zambon J; Ciancio S; Schneir M
    J Periodontal Res; 1984 Nov; 19(6):651-5. PubMed ID: 6098638
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical use of tetracyclines in the treatment of periodontal diseases].
    Bokor-Bratić M; Brkanić T
    Med Pregl; 2000; 53(5-6):266-71. PubMed ID: 11089368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nonantimicrobial properties of tetracycline for the treatment of periodontal disease.
    Vernillo AT; Ramamurthy NS; Golub LM; Rifkin BR
    Curr Opin Periodontol; 1994; ():111-8. PubMed ID: 8032451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources.
    Golub LM; Wolff M; Lee HM; McNamara TF; Ramamurthy NS; Zambon J; Ciancio S
    J Periodontal Res; 1985 Jan; 20(1):12-23. PubMed ID: 2983061
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial and non-antimicrobial tetracyclines in human cancer trials.
    Richards C; Pantanowitz L; Dezube BJ
    Pharmacol Res; 2011 Feb; 63(2):151-6. PubMed ID: 20951804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metalloproteinases in the pathogenesis of periodontal diseases.
    Kinane DF
    Curr Opin Dent; 1992 Mar; 2():25-32. PubMed ID: 1520933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of subgingival antimicrobial therapy on the levels of stromelysin and tissue inhibitor of metalloproteinases in gingival crevicular fluid.
    Pourtaghi N; Radvar M; Mooney J; Kinane DF
    J Periodontol; 1996 Sep; 67(9):866-70. PubMed ID: 8884643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs.
    Golub LM; Ramamurthy NS; McNamara TF; Greenwald RA; Rifkin BR
    Crit Rev Oral Biol Med; 1991; 2(3):297-321. PubMed ID: 1654139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enzyme activity and immunoglobulin content of the gingival fluid in periodontosis].
    Pleshkova LV
    Stomatologiia (Mosk); 1982; 61(5):25-8. PubMed ID: 6755807
    [No Abstract]   [Full Text] [Related]  

  • 19. Treating periodontal diseases with tetracycline-impregnated fibers: data and controversies.
    Greenstein G
    Compend Contin Educ Dent; 1995 May; 16(5):448-55; quiz 456. PubMed ID: 8624985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Personal experiences with the use of peroxidases in the development of periodontal pathology].
    Inf Dent; 1984 May; 66(18):1809-23. PubMed ID: 6381303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.